title: Efficient protection and transfection of small interfering RNA by cationic shell-crosslinked knedel-like nanoparticles.
abstract: Despite the great potential of small interfering RNA (siRNA) as a therapeutic agent, progress in this area has been hampered by a lack of efficient biocompatible transfection agents. Recently, cationic shell-crosslinked knedel-like nanoparticles (cSCKs) were found to possess lower cytotoxicity and better transfection ability for phosphorothioate ODNs and plasmid DNA than the commonly used cationic lipid-based agent Lipofectamine. To determine the usefulness of cSCKs for siRNA transfection, a small library of cSCKs with varying percentage of primary and tertiary amines was assessed for its ability to bind to siRNA, inhibit siRNA degradation in human serum, and to transfect HeLa and mouse macrophage cell lines. The silencing efficiency in HeLa cells was greatest with the cSCK with 100% primary amines (pa100) as determined by their viability following transfection with cytotoxic and non-cytotoxic siRNAs. cSCK-pa100 showed greater silencing efficiency than Lipofectamine 2000 in the HeLa cells, as well in 293T and human bronchial epithelial (HEK) cells, but was comparable in human bronchial epithelial (BEAS-2B) cells and human mammary epithelial (MCF10a) cells. cSCK-pa100 also showed greater silencing of iNOS expression than Lipofectamine 2000 in a mouse macrophage cell line, and provided greater protection from serum degradation, demonstrating its potential usefulness as an siRNA transfection agent. The siRNA silencing of iNOS at lower concentrations of siRNA could be enhanced by complexation with the fusogenic GALA peptide, which was shown to enhance endosomal escape following uptake.
authors.affiliation: Department of Chemistry, Washington University , St. Louis, MO 63130, USA.
authors.forename: Yuefei
authors.initials: Y
authors.lastname: Shen
authors.forename: Huafeng
authors.initials: H
authors.lastname: Fang
authors.forename: Ke
authors.initials: K
authors.lastname: Zhang
authors.forename: Ritu
authors.initials: R
authors.lastname: Shrestha
authors.forename: Karen L
authors.initials: KL
authors.lastname: Wooley
authors.forename: John-Stephen A
authors.initials: JS
authors.lastname: Taylor
mesh_terms: D002412:Cations / Q000008:administration & dosage / Q000737:chemistry*; D016503:Drug Delivery Systems; D005786:Gene Expression Regulation; D006367:HeLa Cells; D006801:Humans; D053758:Nanoparticles / Q000008:administration & dosage / Q000737:chemistry*; D052247:Nitric Oxide Synthase Type II / Q000235:genetics / Q000378:metabolism; D034741:RNA, Small Interfering / Q000008:administration & dosage / Q000737:chemistry / Q000235:genetics; D014162:Transfection
chemical_list: D002412:Cations; D034741:RNA, Small Interfering; C496319:NOS2 protein, human; D052247:Nitric Oxide Synthase Type II
references.citation: J Control Release. 2011 Jan 5;149(1):58-64
references.pmid: 20826039
references.citation: Biochemistry. 1990 Sep 18;29(37):8713-9
references.pmid: 2271551
references.citation: Curr Opin Pharmacol. 2010 Oct;10(5):534-42
references.pmid: 20620113
references.citation: Vascul Pharmacol. 2005 Dec;43(6):390-403
references.pmid: 16256443
references.citation: Mol Pharm. 2011 Aug 1;8(4):1436-42
references.pmid: 21598999
references.citation: Acc Chem Res. 2011 Oct 18;44(10):969-78
references.pmid: 21675721
references.citation: Biochemistry. 1987 Jun 2;26(11):2964-72
references.pmid: 2886149
references.citation: Biomed Res. 2008 Oct;29(5):257-66
references.pmid: 18997441
references.citation: J Polym Sci A Polym Chem. 2008;46(22):7578-7583
references.pmid: 19855851
references.citation: RNA. 2010 Jul;16(7):1429-35
references.pmid: 20498459
references.citation: Biopolymers. 2010;94(6):763-70
references.pmid: 20564044
references.citation: Int J Nanomedicine. 2011;6:1017-25
references.pmid: 21720513
references.citation: Biomaterials. 2010 Aug;31(24):6355-62
references.pmid: 20537380
references.citation: Bioconjug Chem. 2008 Sep;19(9):1880-7
references.pmid: 18690739
references.citation: Mol Ther. 2010 Mar;18(3):561-9
references.pmid: 20010917
references.citation: Biomaterials. 2012 Nov;33(33):8557-68
references.pmid: 22901966
references.citation: Adv Drug Deliv Rev. 2004 Apr 23;56(7):967-85
references.pmid: 15066755
references.citation: Bioconjug Chem. 2007 Mar-Apr;18(2):456-68
references.pmid: 17326672
references.citation: Tetrahedron. 2008 Sep 1;64(36):8543-8552
references.pmid: 19727320
references.citation: Trends Biotechnol. 2010 Nov;28(11):570-9
references.pmid: 20833440
references.citation: Biochemistry. 1994 May 31;33(21):6721-31
references.pmid: 8204607
references.citation: Nat Rev Drug Discov. 2009 Feb;8(2):129-38
references.pmid: 19180106
references.citation: Biomacromolecules. 2008 Jul;9(7):1997-2006
references.pmid: 18510359
references.citation: Anal Bioanal Chem. 2008 Aug;391(8):2717-27
references.pmid: 18351325
references.citation: J Control Release. 2011 Dec 20;156(3):374-80
references.pmid: 21864599
references.citation: J Biochem. 1997 Jan;121(1):38-46
references.pmid: 9058189
references.citation: Mol Ther. 2004 Aug;10(2):373-85
references.pmid: 15294184
references.citation: Bioconjug Chem. 2009 May 20;20(5):953-9
references.pmid: 19388672
references.citation: Bioconjug Chem. 2008 Dec;19(12):2535-42
references.pmid: 19012426
references.citation: AAPS J. 2010 Dec;12(4):492-503
references.pmid: 20544328
references.citation: Biochemistry. 1990 Sep 18;29(37):8720-8
references.pmid: 2271552
references.citation: Biomaterials. 2010 Mar;31(7):1805-13
references.pmid: 19878990
references.citation: Pharmacol Res. 2010 Aug;62(2):100-14
references.pmid: 20006707
references.citation: J Control Release. 2011 May 10;151(3):220-8
references.pmid: 21078351
references.citation: Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7297-301
references.pmid: 7638184
references.citation: Biotechnol Bioeng. 2007 Jul 1;97(4):909-21
references.pmid: 17154307
references.citation: J Gene Med. 2005 Nov;7(11):1450-8
references.pmid: 16025556
references.citation: Bioorg Med Chem Lett. 2010 Jun 1;20(11):3203-7
references.pmid: 20399650
references.citation: Proc Am Thorac Soc. 2009 Aug 15;6(5):450-7
references.pmid: 19687218
references.citation: Angew Chem Int Ed Engl. 2009;48(8):1378-98
references.pmid: 19153977
references.citation: Biomaterials. 2009 Feb;30(5):968-77
references.pmid: 19038441
references.citation: Int J Pharm. 2005 Oct 13;303(1-2):1-7
references.pmid: 16139452
references.citation: J Control Release. 2009 Oct 15;139(2):127-32
references.pmid: 19540888
references.citation: Methods Mol Biol. 2011;683:525-33
references.pmid: 21053154
references.citation: Am J Physiol Renal Physiol. 2012 Feb 15;302(4):F421-32
references.pmid: 22114207
references.citation: J Control Release. 2009 Jul 1;137(1):46-53
references.pmid: 19303038
references.citation: Mol Pharm. 2011 Jun 6;8(3):758-66
references.pmid: 21449536
references.citation: Gene Ther. 1999 Nov;6(11):1798-807
references.pmid: 10602375
references.citation: Biochim Biophys Acta. 2011 Nov-Dec;1809(11-12):732-45
references.pmid: 21679781